ETX-19477

N/A

Report date: 2026/01/09 15:58:35

Base Information

Drug NameETX-19477
Drug Alias NameETX-19477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors
TargetsPoly(ADP-ribose) glycohydrolase
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies858 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies858 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A